I feel bad for Clay Siegall and the Seattle Genetics. The new presidential administration has declared war on facts. That is not hyperbole, opinion or conjecture. The Trump administration has rejected scientific truths in lieu of emotional beliefs. They are actively fighting the EPA, climate change science, criminal justice science and economic math.
This governmental resistance will come as a blow to Seattle Genetics and Clay Siegall. Clay Siegall is the CEO of the Seattle-based biotech company that employs more than 1000 people in the Pacific Northwest. He has spent his life in rigorous pursuit of scientific truths. For years, he toiled in the trenches as a scientific researcher of cancer.
Companies like Seattle Genetics need money in order to perform vital research. The Trump administration has promised deep budget cuts across the board which may affect cancer research. But what is really affecting Seattle Genetics and Clay Siegall is the war on facts.
Clay Siegall believes in scientific facts. All you need to do is go check out his blog to see his unwavering commitment to science. It is littered with stories about climate change, how the average citizen can navigate the repeal of Obama care, and scientific news from deep space. What is most heartbreaking is that he reposted a story by NPR about fake news and the Trump administration’s assault on science.
What is unexpected is his love for NFL football. He has also reposted plenty of stories about player movements this off-season. It really gives him a down to earth feel which is pretty cool because he is such a giant in the science industry. It makes it really easy to root for him in the situation.
And we should all be rooting for Clay Siegall. As CEO of Seattle Genetics, he has raised over $1.2 billion from private and public entities for cancer research. With federal budget cuts, his job may become more difficult. And that should come as a sad news for anybody rooting for cancer patients. His company tailors individualized cancer treatments that can really make a difference in a cancer patient’s life.